Beckman Research Institute Milestones
These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.